Carregant...
A Drug Pricing “Transparency” Bill With Strong Bipartisan Support But Would It Accomplish Much?
Several drug-price “remedy” bills are floating around Congress, with most being described as a “first step.” So why is no one referring to that step as significant?
Guardat en:
| Publicat a: | P T |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MediMedia USA, Inc.
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6534173/ https://ncbi.nlm.nih.gov/pubmed/31160865 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|